Clinical Trial Update: Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating remission-related outcomes of a metabolic intervention with Forxiga in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: Population Health Research Institute | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2020-11-24